Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
62 hedge funds and large institutions have $464M invested in Repare Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 13 closing their positions.
174,800% more call options, than puts
Call options by funds: $1.75M | Put options by funds: $1K
17% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 18
0.43% less ownership
Funds ownership: 78.31% → 77.88% (-0.43%)
7% less funds holding
Funds holding: 67 → 62 (-5)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
33% less capital invested
Capital invested by funds: $689M → $464M (-$225M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$14.8M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$8.36M |
| 3 |
CA
CHI Advisors
New York
|
+$5.47M |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$2.92M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$35.9M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$3.94M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$2.82M |
| 4 |
Millennium Management
New York
|
-$1.64M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.56M |
RPTX Hedge Fund Activity: Q1 2022 in Review
62 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2022, worth a combined $464M — down 33% from $689M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of RPTX and 8 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 21 added.
The largest buyer was BVF Inc, adding an estimated $14.8M. The largest seller was Logos Global Management, exiting entirely with an estimated $35.9M sold.
- 62 institutional investors held Repare Therapeutics (RPTX) as of Q1 2022, down from 67 in Q4 2021.
- Funds reported $464M of Repare Therapeutics stock for Q1 2022, down 33% quarter-over-quarter.
- 8 funds opened new Repare Therapeutics positions in Q1 2022 and 13 closed out, a net change of -5 holders.
- The largest Repare Therapeutics buyer in Q1 2022 was BVF Inc, an estimated $14.8M added.
- The largest Repare Therapeutics seller in Q1 2022 was Logos Global Management, an estimated $35.9M sold.
Based on aggregated 13F filings for Q1 2022.